PIMECROLIMUS for Dermatitis atopic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 103 adverse event reports in the FDA FAERS database where PIMECROLIMUS was used for Dermatitis atopic.
Most Reported Side Effects for PIMECROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 349 | 26.3% | 0 | 16 |
| Treatment failure | 139 | 10.5% | 0 | 0 |
| Psoriasis | 114 | 8.6% | 0 | 9 |
| Off label use | 113 | 8.5% | 0 | 2 |
| Pruritus | 94 | 7.1% | 0 | 4 |
| Erythema | 89 | 6.7% | 0 | 4 |
| Product use in unapproved indication | 86 | 6.5% | 1 | 1 |
| Rash | 82 | 6.2% | 0 | 4 |
| Application site pain | 72 | 5.4% | 0 | 2 |
| Therapeutic product effect incomplete | 65 | 4.9% | 0 | 3 |
| Condition aggravated | 59 | 4.5% | 0 | 5 |
| Drug ineffective for unapproved indication | 55 | 4.1% | 0 | 0 |
| Eczema | 52 | 3.9% | 0 | 5 |
| Skin exfoliation | 48 | 3.6% | 0 | 3 |
| Application site erythema | 41 | 3.1% | 0 | 1 |
Other Indications for PIMECROLIMUS
Product used for unknown indication (354)
Psoriasis (217)
Eczema (148)
Dermatitis (55)
Rash (52)
Rosacea (46)
Product use in unapproved indication (40)
Pruritus (28)
Dermatitis contact (20)
Vitiligo (20)
Other Drugs Used for Dermatitis atopic
DUPILUMAB (179,563)
UPADACITINIB (5,263)
TRALOKINUMAB-LDRM (3,007)
CRISABOROLE (2,139)
ABROCITINIB (1,616)
NEMOLIZUMAB-ILTO (1,596)
RUXOLITINIB (740)
TACROLIMUS (515)
METHOTREXATE (400)
CYCLOSPORINE (370)